Jobst C. von Einem

949 total citations
33 papers, 659 citations indexed

About

Jobst C. von Einem is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Jobst C. von Einem has authored 33 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Hepatology. Recurrent topics in Jobst C. von Einem's work include Colorectal Cancer Treatments and Studies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Genetic factors in colorectal cancer (8 papers). Jobst C. von Einem is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Genetic factors in colorectal cancer (8 papers). Jobst C. von Einem collaborates with scholars based in Germany, Austria and Netherlands. Jobst C. von Einem's co-authors include Volker Heinemann, Dominik Paul Modest, Marlies Michl, Julian Walter Holch, Sebastian Stintzing, Christiane J. Bruns, Ludwig Fischer von Weikersthal, Christoph Schulz, Hanno Nieß and Peter J. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Jobst C. von Einem

33 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jobst C. von Einem Germany 15 456 178 157 140 118 33 659
Ingvild Moberg Norway 5 426 0.9× 175 1.0× 114 0.7× 193 1.4× 90 0.8× 8 662
Giulia Orsi Italy 12 220 0.5× 148 0.8× 55 0.4× 115 0.8× 113 1.0× 34 514
Hongfei Gao China 14 260 0.6× 174 1.0× 121 0.8× 96 0.7× 203 1.7× 52 536
Kristoffer Staal Rohrberg Denmark 14 430 0.9× 189 1.1× 64 0.4× 198 1.4× 169 1.4× 59 696
Kaija Vasala Finland 14 251 0.6× 58 0.3× 156 1.0× 97 0.7× 120 1.0× 27 483
Pamela Biondani Italy 12 341 0.7× 162 0.9× 75 0.5× 105 0.8× 79 0.7× 37 505
Jiemin Zhao China 12 612 1.3× 187 1.1× 74 0.5× 115 0.8× 137 1.2× 28 856
Renjie Yang China 16 129 0.3× 124 0.7× 161 1.0× 202 1.4× 144 1.2× 50 694
Xiaochu Yan China 13 289 0.6× 136 0.8× 69 0.4× 184 1.3× 130 1.1× 33 801
S. Sulfaro Italy 9 203 0.4× 51 0.3× 119 0.8× 67 0.5× 54 0.5× 13 564

Countries citing papers authored by Jobst C. von Einem

Since Specialization
Citations

This map shows the geographic impact of Jobst C. von Einem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jobst C. von Einem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jobst C. von Einem more than expected).

Fields of papers citing papers by Jobst C. von Einem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jobst C. von Einem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jobst C. von Einem. The network helps show where Jobst C. von Einem may publish in the future.

Co-authorship network of co-authors of Jobst C. von Einem

This figure shows the co-authorship network connecting the top 25 collaborators of Jobst C. von Einem. A scholar is included among the top collaborators of Jobst C. von Einem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jobst C. von Einem. Jobst C. von Einem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walter, Annette O., Jobst C. von Einem, Sebastian Stintzing, et al.. (2024). Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients. Cells. 14(1). 32–32. 2 indexed citations
3.
Kurreck, Annika, Volker Heinemann, Ludwig Fischer von Weikersthal, et al.. (2022). Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial. Frontiers in Oncology. 12. 751453–751453. 2 indexed citations
4.
Heinemann, Volker, Michael Geißler, Ludwig Fischer von Weikersthal, et al.. (2022). Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy. Cancers. 14(3). 526–526. 4 indexed citations
5.
Stahler, Arndt, Volker Heinemann, Julian Walter Holch, et al.. (2021). Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE‐3). International Journal of Cancer. 149(11). 1935–1943. 1 indexed citations
7.
Stahler, Arndt, Sebastian Stintzing, Jobst C. von Einem, et al.. (2020). Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. European Journal of Cancer. 137. 250–259. 22 indexed citations
8.
Stahler, Arndt, Volker Heinemann, Ingrid Ricard, et al.. (2020). Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials. Journal of Cancer Research and Clinical Oncology. 146(8). 2077–2087. 9 indexed citations
9.
Einem, Jobst C. von, Sebastian Stintzing, Dominik Paul Modest, et al.. (2020). Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients. Cureus. 12(3). e7305–e7305. 5 indexed citations
10.
Einem, Jobst C. von, Christine Guenther, Hans‐Dieter Volk, et al.. (2019). Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial. International Journal of Cancer. 145(6). 1538–1546. 56 indexed citations
11.
Fiedler, Walter, Jobst C. von Einem, Henk M.W. Verheul, et al.. (2018). Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma. Annals of Oncology. 29. viii139–viii140. 18 indexed citations
12.
Holch, Julian Walter, Ingrid Ricard, Sebastian Stintzing, et al.. (2018). Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). European Journal of Cancer. 106. 115–125. 16 indexed citations
13.
Holch, Julian Walter, Marlies Michl, Christoph Schulz, et al.. (2017). Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer. Visceral Medicine. 33(1). 70–75. 58 indexed citations
14.
Nieß, Hanno, Jobst C. von Einem, Michael Thomas, et al.. (2015). Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial. BMC Cancer. 15(1). 237–237. 86 indexed citations
15.
Haas, Michael, Christoph Kern, Stephan Krüger, et al.. (2014). Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3. Tumor Biology. 36(4). 2631–2640. 12 indexed citations
16.
Einem, Jobst C. von, Hanno Nieß, Marlies Michl, et al.. (2014). TREAT-ME 1: Treatment of advanced gastrointestinal cancer in a clinical phase I/II trial with genetically modified mesenchymal stem cells.. Journal of Clinical Oncology. 32(15_suppl). TPS3122–TPS3122. 1 indexed citations
17.
Einem, Jobst C. von, Volker Heinemann, Ludwig Fischer von Weikersthal, et al.. (2014). Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. Journal of Cancer Research and Clinical Oncology. 140(9). 1607–1614. 89 indexed citations
18.
Cyran, Clemens C., Bettina Schwarz, Philipp M. Paprottka, et al.. (2013). In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media. Cancer Imaging. 13(4). 557–566. 7 indexed citations
19.
Modest, Dominik Paul, Christoph Schulz, Ludwig Fischer von Weikersthal, et al.. (2013). Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut). Anti-Cancer Drugs. 25(2). 212–218. 39 indexed citations
20.
Cyran, Clemens C., Jobst C. von Einem, Philipp M. Paprottka, et al.. (2011). Dynamic Contrast-Enhanced Computed Tomography Imaging Biomarkers Correlated With Immunohistochemistry for Monitoring the Effects of Sorafenib on Experimental Prostate Carcinomas. Investigative Radiology. 47(1). 49–57. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026